These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 14985492

  • 21. Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
    Paré P.
    Can J Gastroenterol; 2001 Nov; 15(11):751-6. PubMed ID: 11727005
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Anti-tumour necrosis factor-alpha therapies in Crohn's disease.
    Sprakes MB, Hamlin PJ.
    Br J Hosp Med (Lond); 2009 Nov; 70(11):644-7. PubMed ID: 20081592
    [Abstract] [Full Text] [Related]

  • 24. Infliximab for the treatment of fistulas in patients with Crohn's disease.
    Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, Podolsky DK, Sands BE, Braakman T, DeWoody KL, Schaible TF, van Deventer SJ.
    N Engl J Med; 1999 May 06; 340(18):1398-405. PubMed ID: 10228190
    [Abstract] [Full Text] [Related]

  • 25. Infliximab in pediatric Crohn disease patients with enterovesicular fistulas.
    Teitelbaum JE, Saeed S, Triantafyllopoulou M, Daum F.
    J Pediatr Gastroenterol Nutr; 2007 Feb 06; 44(2):279-82. PubMed ID: 17255846
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
    Bor R, Farkas K, Bálint A, Szűcs M, Abrahám S, Baradnay G, Wittmann T, Szepes Z, Nagy F, Molnár T.
    Orv Hetil; 2013 Dec 08; 154(49):1943-8. PubMed ID: 24292112
    [Abstract] [Full Text] [Related]

  • 30. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D.
    Colorectal Dis; 2005 Mar 08; 7(2):164-8. PubMed ID: 15720356
    [Abstract] [Full Text] [Related]

  • 31. Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort.
    Pittet V, Juillerat P, Michetti P, Vader JP, Burnand B, Rogler G, Beglinger C, Seibold F, Mottet C, Felley C, Gonvers JJ, Froehlich F, Swiss IBD Cohort Study Group.
    Aliment Pharmacol Ther; 2010 Oct 08; 32(8):1007-16. PubMed ID: 20937046
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine.
    Schröder O, Blumenstein I, Schulte-Bockholt A, Stein J.
    Aliment Pharmacol Ther; 2004 Feb 01; 19(3):295-301. PubMed ID: 14984376
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study].
    Doubremelle M, Bourreille A, Zerbib F, Heresbach D, Metman EH, Beau P, Gournay J, Galmiche JP.
    Gastroenterol Clin Biol; 2002 Nov 01; 26(11):973-9. PubMed ID: 12483127
    [Abstract] [Full Text] [Related]

  • 38. Re: Fefferman et al.--"Recurrence" of chronic pancreatitis appearing on a patient with underlying Crohn's disease.
    Triantafillidis JK, Cheracakis P.
    Am J Gastroenterol; 2002 Mar 01; 97(3):761-2. PubMed ID: 11922579
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.